MyD88 deletion inhibited colitis development in a model of spontaneous colitis (SHP-2 IEC-KO mice), rescued the goblet/intermediate cell ratio and prevented NFκB hyperactivation and inflammation [47]. This evidence concerns the gene NFKB1 and colitis.